| scholarly article | Q13442814 |
| P50 | author | Julianne H Grose | Q60961874 |
| Junichi Sadoshima | Q51313947 | ||
| P2093 | author name string | Huali Zhang | |
| Ivor J Benjamin | |||
| Soumyajit Banerjee Mustafi | |||
| Elisabeth S Christians | |||
| Gregory W Pratt | |||
| P2860 | cites work | A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy | Q24311671 |
| DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway | Q24312506 | ||
| PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse | Q24619841 | ||
| Guidelines for the nomenclature of the human heat shock proteins | Q24653946 | ||
| Lysine acetylation targets protein complexes and co-regulates major cellular functions | Q27860589 | ||
| The thioredoxin system protects ribosomes against stress-induced aggregation | Q27935088 | ||
| HspB8 and Bag3: a new chaperone complex targeting misfolded proteins to macroautophagy | Q28261719 | ||
| Acetylation of non-histone proteins modulates cellular signalling at multiple levels | Q28294575 | ||
| AlphaB-crystallin in lens development and muscle integrity: a gene knockout approach | Q28512665 | ||
| HDAC3-dependent reversible lysine acetylation of cardiac myosin heavy chain isoforms modulates their enzymatic and motor activity | Q30498149 | ||
| Thioredoxin converts the Syrian hamster (29-231) recombinant prion protein to an insoluble form | Q31861557 | ||
| BAG3 directly interacts with mutated alphaB-crystallin to suppress its aggregation and toxicity | Q33851451 | ||
| Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy | Q34015864 | ||
| Thioredoxin and thioredoxin reductase: current research with special reference to human disease | Q34116992 | ||
| Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis | Q34146310 | ||
| Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice | Q34231667 | ||
| Selective degradation of aggregate-prone CryAB mutants by HSPB1 is mediated by ubiquitin-proteasome pathways | Q34288280 | ||
| Gold complexes in the treatment of rheumatoid arthritis. | Q34327789 | ||
| HSPB2 is dispensable for the cardiac hypertrophic response but reduces mitochondrial energetics following pressure overload in mice | Q34369276 | ||
| Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy | Q34442070 | ||
| Redox signaling in cardiac myocytes. | Q34629326 | ||
| Mitochondrial Thioredoxin Reductase Is Essential for Early Postischemic Myocardial Protection | Q60606962 | ||
| Thioredoxin and thioredoxin reductase | Q71521704 | ||
| Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors | Q73694288 | ||
| Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice | Q74147604 | ||
| Aurothioglucose inhibits murine thioredoxin reductase activity in vivo | Q77897156 | ||
| Differential regulation of expression of cytosolic and mitochondrial thioredoxin reductase in rat liver and kidney | Q79754197 | ||
| Effect of selenium on thioredoxin reductase activity in Txnrd1 or Txnrd2 hemizygous mice | Q81443297 | ||
| A novel CRYAB mutation resulting in multisystemic disease | Q84948868 | ||
| Redox proteomics of thiol proteins in mouse heart during ischemia/reperfusion using ICAT reagents and mass spectrometry | Q86045495 | ||
| Redox signaling and cardiac sarcomeres | Q34696170 | ||
| A knock-in mouse model for the R120G mutation of αB-crystallin recapitulates human hereditary myopathy and cataracts. | Q34699001 | ||
| Sustained activation of nuclear erythroid 2-related factor 2/antioxidant response element signaling promotes reductive stress in the human mutant protein aggregation cardiomyopathy in mice | Q35040534 | ||
| Autophagy and p62 in cardiac proteinopathy. | Q35124250 | ||
| Atg7 induces basal autophagy and rescues autophagic deficiency in CryABR120G cardiomyocytes. | Q35149003 | ||
| Desmin-related cardiomyopathy: an unfolding story | Q35395372 | ||
| Genetics of inherited cardiomyopathy. | Q35721684 | ||
| ASEB: a web server for KAT-specific acetylation site prediction. | Q36088348 | ||
| Mechanistic insights into the regulation of metabolic enzymes by acetylation | Q36135254 | ||
| Small heat shock proteins in redox metabolism: implications for cardiovascular diseases | Q36143828 | ||
| Reductive stress linked to small HSPs, G6PD, and Nrf2 pathways in heart disease | Q36596623 | ||
| On the potential of thioredoxin reductase inhibitors for cancer therapy | Q36631139 | ||
| Autophagy is an adaptive response in desmin-related cardiomyopathy | Q36775392 | ||
| Global expression profiling identifies a novel biosignature for protein aggregation R120GCryAB cardiomyopathy in mice | Q36956214 | ||
| Mutation R120G in alphaB-crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function | Q37198800 | ||
| Elucidation of thioredoxin target protein networks in mouse. | Q37258100 | ||
| Hydrogen sulfide mediates cardioprotection through Nrf2 signaling | Q37328256 | ||
| Cardioprotection: a radical view Free radicals in pre and postconditioning | Q37402889 | ||
| Focus on mammalian thioredoxin reductases--important selenoproteins with versatile functions | Q37443200 | ||
| Transgenic mouse models for the vital selenoenzymes cytosolic thioredoxin reductase, mitochondrial thioredoxin reductase and glutathione peroxidase 4. | Q37477495 | ||
| BAG3: a multifaceted protein that regulates major cell pathways | Q37862582 | ||
| Molecular mechanisms of α-crystallinopathy and its therapeutic strategy | Q37951175 | ||
| Small molecule inhibitors of mammalian thioredoxin reductase. | Q37953771 | ||
| Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives. | Q38031633 | ||
| Interacting with thioredoxin-1--disease or no disease? | Q38032332 | ||
| The thioredoxin system as a therapeutic target in human health and disease. | Q38067821 | ||
| Proteotoxicity and cardiac dysfunction--Alzheimer's disease of the heart? | Q38077849 | ||
| Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts | Q40337309 | ||
| Biochemical and mechanical dysfunction in a mouse model of desmin-related myopathy | Q41826353 | ||
| Nrf2-mediated resistance to oxidant-induced redox disruption in embryos | Q42718951 | ||
| Distinct chaperone mechanisms can delay the formation of aggresomes by the myopathy-causing R120G alphaB-crystallin mutant | Q42800500 | ||
| Residue R120 is essential for the quaternary structure and functional integrity of human alphaB-crystallin. | Q42826216 | ||
| Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice | Q43012174 | ||
| Loss of thioredoxin function in retinas of mice overexpressing amyloid β. | Q43854273 | ||
| Selenium regulation of thioredoxin reductase activity and mRNA levels in rat liver | Q44006328 | ||
| Thioredoxin reductase in human hepatoma cells is transcriptionally regulated by sulforaphane and other electrophiles via an antioxidant response element | Q44569322 | ||
| Ischemia-induced phosphorylation and translocation of stress protein alpha B-crystallin to Z lines of myocardium. | Q48014059 | ||
| Tissue distribution and developmental profiles of immunoreactive alpha B crystallin in the rat determined with a sensitive immunoassay system | Q48720190 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 18 | |
| P304 | page(s) | 2891-2906 | |
| P577 | publication date | 2014-02-04 | |
| P1433 | published in | Antioxidants & Redox Signaling | Q4775078 |
| P1476 | title | Aggregate-prone R120GCRYAB triggers multifaceted modifications of the thioredoxin system | |
| P478 | volume | 20 |
| Q46265580 | Acetylation Regulates Thioredoxin Reductase Oligomerization and Activity. |
| Q47952887 | BAG3-mediated proteostasis at a glance |
| Q37686453 | BMI1, a new target of CK2α |
| Q39687663 | MDR1 mediated chemoresistance: BMI1 and TIP60 in action |
| Q46156138 | Mitochondrial BMI1 maintains bioenergetic homeostasis in cells |
| Q34547638 | Modulation of signaling mechanisms in the heart by thioredoxin 1. |
| Q89860827 | Neuromuscular Diseases Due to Chaperone Mutations: A Review and Some New Results |
| Q47347524 | The role of αB-crystallin in skeletal and cardiac muscle tissues |
Search more.